Capricor Therapeutics, Inc. (CAPR) Social Stream
Capricor Therapeutics Inc (CAPR) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Capricor Therapeutics Inc.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 43 weeks, CAPR's average price target has gone up $2.5.
Over the past 18 months, CAPR's average upside potential has been 142.88%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
CAPR Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- CAPR has a greater upside potential (average analyst target price relative to current price) than 95.41% of all US stocks.
- Capricor Therapeutics Inc's number of analysts covering the stock is greater than 5.61% of Pharmaceutical Products stocks.
- CAPR has a less variance in analysts' estimates than 86.27% of Pharmaceutical Products stocks.
- CAPR has a higher average analyst price target than 14.2% of all US stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Capricor Therapeutics Inc are CGTX, GLTO and ENTX.
What is the outlook for CAPR? Use POWR Ratings for clearer insight into price direction.